Australia markets closed

ADC Therapeutics SA (ADCT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.1000+0.0100 (+0.24%)
At close: 04:00PM EDT
4.1300 +0.03 (+0.73%)
After hours: 06:08PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-227,285
-240,053
-157,128
-230,026
-246,290
Depreciation & amortisation
3,387
3,267
2,388
2,630
1,972
Deferred income taxes
37,173
37,104
-1,621
-26,049
0
Stock-based compensation
5,579
13,495
49,322
60,480
37,585
Change in working capital
1,437
44,271
-48,725
-15,710
12,689
Accounts receivable
883
47,789
-42,753
-30,218
0
Inventory
-5,932
-5,712
-9,651
-3,022
0
Accounts payable
5,589
3,173
310
6,798
1,921
Other working capital
-150,120
-121,902
-138,998
-239,754
-171,538
Other non-cash items
22,690
17,303
-25,406
-17,055
49,399
Net cash provided by operating activities
-147,389
-118,686
-138,311
-233,378
-168,729
Cash flows from investing activities
Investments in property, plant and equipment
-2,731
-3,216
-687
-6,376
-2,809
Other investing activities
-
-
-210
-297
-19
Net cash used for investing activities
-2,731
-3,216
-687
-6,673
-2,828
Cash flows from financing activities
Debt repayment
-
-
-1,011
-977
-1,144
Common stock issued
-
0
6,130
0
433,158
Common stock repurchased
-
-
-221
0
0
Other financing activities
-
73,102
-122,624
218,002
-
Net cash used provided by (used for) financing activities
73,806
73,875
-897
267,394
494,966
Net change in cash
-76,314
-48,027
-139,895
27,343
323,409
Cash at beginning of period
310,547
326,441
466,544
439,195
115,551
Cash at end of period
234,233
278,598
326,441
466,544
439,195
Free cash flow
Operating cash flow
-147,389
-118,686
-138,311
-233,378
-168,729
Capital expenditure
-2,731
-3,216
-687
-6,376
-2,809
Free cash flow
-150,120
-121,902
-138,998
-239,754
-171,538